Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Mapkure LLC has 2 pending office actions in the Medical Devices & Mechanical Engineering technology area. These actions are split between 2 distinct examiners and 2 distinct art units. BREDEFELD, RACHAEL EVA is the busiest examiner with 1 pending office action, reflecting a distributed prosecution across different examination groups. This lack of examiner concentration means that the company's prosecution results are subject to the individual discretion of two different officials.
The 2 distinct art units involved suggest that the company's medical innovations are being reviewed by different specialized groups. This variety requires a case-by-case approach to prosecution rather than a single unified strategy. With 2 distinct examiners involved, practitioners should expect to navigate two different examination styles across the 2 distinct art units. This distribution helps mitigate the risk that a single examiner's negative trend could impact the entire pending portfolio.
Because BREDEFELD, RACHAEL EVA and the other distinct examiner each have only 1 pending office action, the workload is evenly spread. This balance is a key feature of the company's current prosecution profile in the Medical Devices & Mechanical Engineering sector. The presence of 2 distinct art units indicates that the technology being prosecuted is diverse enough to be routed to different technical groups at the USPTO.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BREDEFELD, RACHAEL EVA | 1 | 27.4% | +35.0% |
| CORNET, JEAN P | 1 | 41.9% | +47.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18487237 | COMBINATION FOR USE IN TREATING CANCERS | CORNET, JEAN P | 23d overdue |
| 18966838 | Methods of Treating Cancer With a B-RAF Inhibitor | BREDEFELD, RACHAEL EVA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18487237 | COMBINATION FOR USE IN TREATING CANCERS | CORNET, JEAN P | 23d overdue |
| 18966838 | Methods of Treating Cancer With a B-RAF Inhibitor | BREDEFELD, RACHAEL EVA | — |
| Art Unit | Apps |
|---|---|
| 3786 | 1 |
| 1628 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18966838 | Methods of Treating Cancer With a B-RAF Inhibitor | BREDEFELD, RACHAEL EVA | 3786 | §103§112DP | Non-Final OA | — | Pending | Dec 03, 2024 |
| 18487237 | COMBINATION FOR USE IN TREATING CANCERS | CORNET, JEAN P | 1628 | §103§112Other | Final Rejection | 23d overdue | Pending | Oct 16, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMapkure LLC has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Rachael Eva Bredefeld has the most, with 1 of Mapkure LLC's pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
